3 Biotech Stocks That Could Double Before 2016
Here is a look at three small-cap biotech stocks with the potential to double within the next six months.
3 Experimental Cancer Drugs Investors Should Be Closely Watching
Meet the drugs our experts believe have shown the most promising results in the race to cure cancer.
This Biotech Stock Has Jaw-Dropping Growth Potential
Geron Corp. is small-cap biotech with major growth potential.